Oxidative Stress Is Progressively Enhanced With Advancing Stages of CKD Evangelia Dounousi, MD, Eleni Papavasiliou, MSc, Areti Makedou, MD, Kyriakos Ioannou,

Slides:

Advertisements

Similar presentations

Fredrik Karlsson, MD, Angelo Modica, MD, Thomas Mooe, MD, PhD

Advertisements

The Epidemiology of Hemoglobin Levels in Patients With Type 2 Diabetes

Renal Function Testing

Uric Acid and Long-term Outcomes in CKD

Peritoneal dialysis American Journal of Kidney Diseases

Uric Acid as a Target of Therapy in CKD

Olivier Niel, MD, PhD, Charlotte Boussard, MSc, Paul Bastard, MSc

GFR Estimation Using Cystatin C Is Not Independent of Body Composition

Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management Uday M Khosla, MD, Richard J.

Citrate Plasma Levels in Patients Under Regional Anticoagulation in Continuous Venovenous Hemofiltration Gerd R. Hetzel, MD, Gediz Taskaya, Christoph.

Francesca Mallamaci, MD, Giovanni Tripepi, PhD

Dorian Schatell, MS, Meg Wise, PhD, Kristi Klicko, CHES, Bryan N

Edmund J. Bini, MD, MPH, Aditi Kinkhabwala, MD, David S. Goldfarb, MD

Kostas C. Siamopoulos, MD, FRSH, Chariklia Gouva, MD, Konstantinos P

Amir Said Alizadeh Naderi, MD, Biff F. Palmer, MD

A Decade After the KDOQI CKD Guidelines

Quiz Page November 2016 American Journal of Kidney Diseases

Impact of Comorbidities on Mortality in Managed Care Patients With CKD

Renal Manifestations of Plasma Cell Disorders

Dialysis Facility Ownership and Epoetin Dosing in Hemodialysis Patients: A Dialysis Provider’s Perspective J. Michael Lazarus, MD, Raymond M. Hakim,

What Is the Goal With Endogenous Filtration Markers—Estimation of GFR or Prediction of Kidney Outcomes? Andrew D. Rule, MD, MSc, Kent R. Bailey, PhD,

Evaluation of the Potential Living Kidney Donor

Hai-yan Wang, MD, American Journal of Kidney Diseases

Focusing on Health Literacy Might Help Us Cross the Quality Chasm

Daniel E. Weiner, MD, MS American Journal of Kidney Diseases

Febuxostat in Hyperuricemic Patients With Advanced CKD

J-Shaped Mortality Relationship for Uric Acid in CKD

Effect of Fish Oil on Vitamin D Absorption

Karl D. Nolph, MD, American Journal of Kidney Diseases

Hemoglobin Level and Transfusions in Patients on Maintenance Dialysis: Where the Rubber Meets the Road Eduardo Lacson, MD, MPH, Franklin Maddux, MD

Navdeep Tangri, MD, FRCPC, Daniel E. Weiner, MD, MS

Geriatrics American Journal of Kidney Diseases

Usability Testing and Acceptance of an Electronic Medication Inquiry System for CKD Patients Clarissa J. Diamantidis, MD, MHS, Marni Zuckerman, MA, Wanda.

Quiz Page July 2012 American Journal of Kidney Diseases

Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management Uday M Khosla, MD, Richard J.

Polyunsaturated Fatty Acids and Kidney Disease

A Decade After the KDOQI CKD Guidelines: A Perspective From Mexico

High Prevalence and Low Awareness of CKD in Taiwan: A Study on the Relationship Between Serum Creatinine and Awareness From a Nationally Representative.

CPR 1.2.: Evaluation of Anemia in CKD

Parathyromatosis and the Challenge of Treatment

A Role for Bromine Deficiency in Sleep Disturbances of Long-Term Dialysis Patients Caterina Canavese, MD, Ester De Costanzi, MD, Piero Stratta, MD, Enrico.

Risks and Outcomes of Acute Kidney Injury Requiring Dialysis After Cardiac Transplantation Janet M. Boyle, MD, Soundous Moualla, MD, Susana Arrigain,

Prevalence and Severity of Renal Disease in Familial Dysautonomia

Quiz Page April 2008 American Journal of Kidney Diseases

Study Designs in Patient-Oriented Research

Daniel T. Lackland, DrPH, David J.P. Barker, MD, PhD

Daniel E. Weiner, MD, MS, Mark J. Sarnak, MD, MS

Lesley A. Stevens, MD, MS, Nicholas Stoycheff, MD

Long-term Outcomes of Acute Kidney Injury: The Power and Pitfalls of Observational/Population-Based Studies Charuhas V. Thakar, MD American Journal.

Arnold S. Relman, MD, American Journal of Kidney Diseases

Lesley A. Stevens, MD, MS, Josef Coresh, MD, PhD, Andrew S. Levey, MD

Trial Quality in Nephrology: How Are We Measuring Up?

Making Music American Journal of Kidney Diseases

Achieving Fairness in Access to Kidney Transplant: A Work in Progress

Anil K. Saxena, MD, B.R. Panhotra, MD, PhD, MNAMS

James F. Winchester, MD, Thomas H. Hostetter, MD, Timothy W. Meyer, MD

Supportive care for patients with renal disease: Time for action

Quiz Page June 2011 American Journal of Kidney Diseases

This Month in AJKD American Journal of Kidney Diseases

Role of glucocorticoids in acidosis

Ann M. O'Hare, MA, MD American Journal of Kidney Diseases

Metabolic Syndrome and CKD in a General Japanese Population: The Hisayama Study Toshiharu Ninomiya, MD, PhD, Yutaka Kiyohara, MD, PhD, Michiaki Kubo,

Dialysis Research and N-of-1 Trials: Made for Each Other?

Serum Leptin and Epoetin Sensitivity

Clinical Practice Recommendations For Peritoneal Dialysis Adequacy

A Decade After the KDOQI CKD Guidelines: Impact on the National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Adam Whaley-Connell, DO, MSPH

Clinical Practice Guidelines for Peritoneal Dialysis Adequacy

Quiz page December 2003 American Journal of Kidney Diseases

James A. Sloand, MD, Mark A. Shelly, MD

Medication Adherence Behavior and Priorities Among Older Adults With CKD: A Semistructured Interview Study Dena E. Rifkin, MD, MS, M. Barton Laws, PhD,

Presentation transcript:

Oxidative Stress Is Progressively Enhanced With Advancing Stages of CKD Evangelia Dounousi, MD, Eleni Papavasiliou, MSc, Areti Makedou, MD, Kyriakos Ioannou, MD, Konstantinos P. Katopodis, MD, Alexandros Tselepis, MD, PhD, Kostas C. Siamopoulos, MSc, MD, FRSH, Dimitrios Tsakiris, MD, PhD (Glasgow) American Journal of Kidney Diseases Volume 48, Issue 5, Pages 752-760 (November 2006) DOI: 10.1053/j.ajkd.2006.08.015 Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions

Fig 1 Distribution of the 87 patients and mean eGFRs in CKD stages 1 to 4. To convert eGFR in mL/min to mL/s, multiply by 0.01667. American Journal of Kidney Diseases 2006 48, 752-760DOI: (10.1053/j.ajkd.2006.08.015) Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions

Fig 2 Mean plasma 8-epiPGF2a levels in 87 patients with CKD stages 1 to 4 (ANOVA P < 0.001). American Journal of Kidney Diseases 2006 48, 752-760DOI: (10.1053/j.ajkd.2006.08.015) Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions

Fig 3 Correlation of eGFR with plasma 8-epiPGF2a levels in 87 patients. To convert eGFR in mL/min to mL/s, multiply by 0.01667. American Journal of Kidney Diseases 2006 48, 752-760DOI: (10.1053/j.ajkd.2006.08.015) Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions

Fig 4 Mean serum TΑS levels in 87 patients with CKD stages 1 to 4 (ANOVA P < 0.009). American Journal of Kidney Diseases 2006 48, 752-760DOI: (10.1053/j.ajkd.2006.08.015) Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions

Fig 5 Correlation of eGFR with serum TAS levels in 87 patients. To convert eGFR in mL/min to mL/s, multiply by 0.01667. American Journal of Kidney Diseases 2006 48, 752-760DOI: (10.1053/j.ajkd.2006.08.015) Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions

Fig 6 Correlation of serum TAS and uric acid levels in 87 patients. To convert uric acid in mg/dL to μmol/L, multiply by 59.48. American Journal of Kidney Diseases 2006 48, 752-760DOI: (10.1053/j.ajkd.2006.08.015) Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions